The childhood obesity epidemic in GCC countries has triggered a debate on the potential use of weight-loss medications such ...

Eli Lilly’s LLY popular obesity drug, Zepbound showed better weight loss than Novo Nordisk’s Wegovy in a head-to-head study.

In the fierce race to dominate the weight loss drug market, global pharmaceutical giant Eli Lilly announced on Wednesday that ...

If you want to take Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight management, you might also be exploring telemedicine and the convenience of getting a ...

On average, participants on Zepbound lost 50 pounds, compared to 33 pounds for those on Wegovy. Furthermore, 32% of Zepbound users achieved at least a 25% reduction in body weight, doubling the 16% ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Kathy Bates, Oprah, Ashley Benson and more celebs who've talked about semaglutide drugs including Ozempic and Wegovy — and where they fall on its usage Kate Hogan is Director of Digital Specials ...

Here some of the success stories Your Investment Property has written from everyday Australians and their journey to becoming to property ownership and investment. Get exclusive reports, data, offers, ...

Follow us on Instagram for updates on our services, schedules, highlights, and exciting news! Scan the QR code or search for our handle: usf_asc.

Happy Birthday to Dame Judi Dench, one of the greatest actresses of our time who turns 90 today. A Hollywood and theatre legend, the ...